Evogene Ltd. EVGN

NAS: EVGN | ISIN: IL0011050551 1/05/2025

1,150 USD (+1,77%)

(+1,77%) 1/05/2025

Grafiek Evogene Ltd.

Grafiek Evogene Ltd.

1 dag1d 1,77%
1 week1w 3,60%
1 maand1m -9,45%
3 maanden3m -21,77%
6 maanden6m -44,98%
1 jaar1j 63,00%
5 jaar5j -75,74%

Evogene Ltd. in het nieuws

Toon enkel gratis nieuws

21 april 2025 · ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio · Persbericht

6 maart 2025 · Evogene Reports Fourth Quarter and Full Year 2024 Financial Results · Persbericht

6 maart 2025 · Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 · Persbericht

23 augustus 2024 · Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement · Persbericht

22 augustus 2024 · Evogene Reports Second Quarter 2024 Financial Results · Persbericht

12 augustus 2024 · Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule · Persbericht

12 augustus 2024 · Evogene Schedules Second Quarter 2024 Financial Results Release · Persbericht

31 juli 2024 · Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil · Persbericht

23 juli 2024 · Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split · Persbericht

17 juli 2024 · ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants · Persbericht

Profiel Evogene Ltd.

Gezondheidstechnologie

Website: www.evogene.com

Hoofdzetel: Rehovot Israël

Werknemers: 186

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe